Samantha L. Shterengarts

Array ( [id] => 9524167 [patent_doc_number] => 08748431 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2014-06-10 [patent_title] => 'Microbicidal heterocycles' [patent_app_type] => utility [patent_app_number] => 13/989797 [patent_app_country] => US [patent_app_date] => 2011-11-25 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 16335 [patent_no_of_claims] => 14 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 6 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13989797 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8253085 [patent_doc_number] => 20120157414 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2012-06-21 [patent_title] => 'CANNABINOID RECEPTOR ANTAGONISTS-INVERSE AGONISTS USEFUL FOR TREATING METABOLIC DISORDERS, INCLUDING OBESITY AND DIABETES' [patent_app_type] => utility [patent_app_number] => 13/300351 [patent_app_country] => US [patent_app_date] => 2011-11-18 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 16568 [patent_no_of_claims] => 11 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0157/20120157414.pdf [firstpage_image] =>[orig_patent_app_number] => 13300351 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8359696 [patent_doc_number] => 20120214849 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2012-08-23 [patent_title] => 'DUAL-ACTING ANTIHYPERTENSIVE AGENTS' [patent_app_type] => utility [patent_app_number] => 13/298493 [patent_app_country] => US [patent_app_date] => 2011-11-17 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 46383 [patent_no_of_claims] => 24 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13298493 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 11784941 [patent_doc_number] => 09394287 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2016-07-19 [patent_title] => 'Compounds useful as modulators of TRPM8' [patent_app_type] => utility [patent_app_number] => 13/883349 [patent_app_country] => US [patent_app_date] => 2011-11-04 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 46458 [patent_no_of_claims] => 38 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 8 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13883349 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 9250435 [patent_doc_number] => 08614214 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2013-12-24 [patent_title] => 'Pyrazole amide compounds and uses thereof' [patent_app_type] => utility [patent_app_number] => 13/883146 [patent_app_country] => US [patent_app_date] => 2011-11-02 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 37763 [patent_no_of_claims] => 21 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 11 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13883146 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8990608 [patent_doc_number] => 20130217889 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2013-08-22 [patent_title] => 'NOVEL PHASE TRANSFER CATALYSTS' [patent_app_type] => utility [patent_app_number] => 13/881819 [patent_app_country] => US [patent_app_date] => 2011-10-27 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 9618 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13881819 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 9034879 [patent_doc_number] => 20130237518 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2013-09-12 [patent_title] => 'NOVEL COMPOUNDS THAT ARE ERK INHIBITORS' [patent_app_type] => utility [patent_app_number] => 13/881050 [patent_app_country] => US [patent_app_date] => 2011-10-24 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 39636 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13881050 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8228494 [patent_doc_number] => 20120142686 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2012-06-07 [patent_title] => 'VIRAL POLYMERASE INHIBITORS' [patent_app_type] => utility [patent_app_number] => 13/278021 [patent_app_country] => US [patent_app_date] => 2011-10-20 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 1 [patent_no_of_words] => 62287 [patent_no_of_claims] => 23 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13278021 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8591958 [patent_doc_number] => 08349833 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2013-01-08 [patent_title] => 'Compounds, compositions and methods useful for cholesterol mobilisation' [patent_app_type] => utility [patent_app_number] => 13/276238 [patent_app_country] => US [patent_app_date] => 2011-10-18 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 26 [patent_figures_cnt] => 26 [patent_no_of_words] => 63672 [patent_no_of_claims] => 8 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 6 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13276238 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7768426 [patent_doc_number] => 20120035370 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2012-02-09 [patent_title] => 'Azaindazole Compounds As CCR1 Receptor Antagonists' [patent_app_type] => utility [patent_app_number] => 13/273509 [patent_app_country] => US [patent_app_date] => 2011-10-14 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 63101 [patent_no_of_claims] => 8 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0035/20120035370.pdf [firstpage_image] =>[orig_patent_app_number] => 13273509 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8141261 [patent_doc_number] => 20120095180 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2012-04-19 [patent_title] => 'ISOLATION OF A C5-DEPROTONATED IMIDAZOLIUM, A CRYSTALLINE ABNORMAL N-HETEROCYCLIC CARBENE' [patent_app_type] => utility [patent_app_number] => 13/272969 [patent_app_country] => US [patent_app_date] => 2011-10-13 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 6 [patent_no_of_words] => 10031 [patent_no_of_claims] => 34 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0095/20120095180.pdf [firstpage_image] =>[orig_patent_app_number] => 13272969 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8347891 [patent_doc_number] => 20120208818 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2012-08-16 [patent_title] => 'COMPOUNDS USEFUL AS ANTAGONISTS OF CCR2' [patent_app_type] => utility [patent_app_number] => 13/269697 [patent_app_country] => US [patent_app_date] => 2011-10-10 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 20304 [patent_no_of_claims] => 48 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13269697 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8951259 [patent_doc_number] => 20130197040 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2013-08-01 [patent_title] => 'POLYMORPHS OF DALFAMPRIDINE, PREPARATIONS AND USES THEREOF' [patent_app_type] => utility [patent_app_number] => 13/878422 [patent_app_country] => US [patent_app_date] => 2011-10-08 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 4 [patent_no_of_words] => 4868 [patent_no_of_claims] => 13 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13878422 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8199387 [patent_doc_number] => 20120122846 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2012-05-17 [patent_title] => 'FURO[3,2-d]PYRIMIDINE COMPOUNDS' [patent_app_type] => utility [patent_app_number] => 13/268387 [patent_app_country] => US [patent_app_date] => 2011-10-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 80242 [patent_no_of_claims] => 36 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0122/20120122846.pdf [firstpage_image] =>[orig_patent_app_number] => 13268387 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8128487 [patent_doc_number] => 20120088792 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2012-04-12 [patent_title] => 'Pyridin-2-YL Methylamine Derivatives for Treating Opiate Dependence' [patent_app_type] => utility [patent_app_number] => 13/269452 [patent_app_country] => US [patent_app_date] => 2011-10-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 1 [patent_no_of_words] => 5792 [patent_no_of_claims] => 16 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0088/20120088792.pdf [firstpage_image] =>[orig_patent_app_number] => 13269452 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7757507 [patent_doc_number] => 20120029201 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2012-02-02 [patent_title] => 'PROCESS FOR THE PREPARATION OF CANDESARTAN CILEXETIL' [patent_app_type] => utility [patent_app_number] => 13/267690 [patent_app_country] => US [patent_app_date] => 2011-10-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 3973 [patent_no_of_claims] => 24 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0029/20120029201.pdf [firstpage_image] =>[orig_patent_app_number] => 13267690 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 9162108 [patent_doc_number] => 20130310384 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2013-11-21 [patent_title] => 'Sulfonamide-Containing Compounds' [patent_app_type] => utility [patent_app_number] => 13/877419 [patent_app_country] => US [patent_app_date] => 2011-10-04 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 57470 [patent_no_of_claims] => 29 [patent_no_of_ind_claims] => 10 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13877419 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 9042642 [patent_doc_number] => 20130245280 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2013-09-19 [patent_title] => 'AMINE COMPOUND AND USE FOR SAME' [patent_app_type] => utility [patent_app_number] => 13/878131 [patent_app_country] => US [patent_app_date] => 2011-09-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 5048 [patent_no_of_claims] => 11 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13878131 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7790619 [patent_doc_number] => 20120052175 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2012-03-01 [patent_title] => 'Process of Extracting Isothiocyanates' [patent_app_type] => utility [patent_app_number] => 13/249361 [patent_app_country] => US [patent_app_date] => 2011-09-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 12794 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0052/20120052175.pdf [firstpage_image] =>[orig_patent_app_number] => 13249361 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8916882 [patent_doc_number] => 20130178507 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2013-07-11 [patent_title] => 'SUBSTITUTED BICYCLIC HCV INHIBITORS' [patent_app_type] => utility [patent_app_number] => 13/825807 [patent_app_country] => US [patent_app_date] => 2011-09-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 22259 [patent_no_of_claims] => 55 [patent_no_of_ind_claims] => 17 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13825807 [rel_patent_id] =>[rel_patent_doc_number] =>)